机译:CD200表达及其在浆细胞骨髓瘤中的稳定性的诊断和预后意义
Departments of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA;
Departments of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA;
Departments of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA;
Departments of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA,Division of Hematopathology, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, 4519 TVC, 1301 Medical Center Drive, Nashville, TN 37232-5310, USA;
机译:CD200表达在淋巴恶性肿瘤和浆细胞骨髓瘤中的诊断价值和预后影响。
机译:浆细胞骨髓瘤中CD200表达的免疫表型稳定性。
机译:非骨髓瘤免疫增生性疾病浆细胞CD200表达:临床病理特征及与浆细胞骨髓瘤的比较
机译:使用不同培养基和血清浓度从转染的NSO骨髓瘤细胞中表达人源化单克隆抗体表达的稳定性研究
机译:胸苷激酶1:对恶性肿瘤的诊断和预后意义
机译:CD200表达在淋巴恶性肿瘤和浆细胞骨髓瘤中的诊断价值和预后影响
机译:CD200表达在淋巴恶恶性肿瘤和血浆细胞骨髓瘤中CD200表达的诊断有用性和预后影响